Enzene Launches Drug Discovery Services Division

Enzene Biosciences, a global CDMO announces the launch of a new Drug Discovery Division.

The drug discovery division further expands the CDMOs breadth of services to the biotech industry and complements its fully-connected continuous manufacturing platform (EnzeneX)-equipped biologics manufacturing site, which will open later this summer in the U.S.

Enzene is launching a new Discovery Division at its Pune facility to meet increasing industry demands. This division will offer integrated discovery services, including antibody services, reagent production, and multi-platform assays. The state-of-the-art laboratories are expected to be operational by July, with further expansions planned later in the year.

By integrating its existing capabilities in bioprocessing, product development, and commercialization with its new discovery capabilities, Enzene will be a one-stop solution provider.

Enzenes Pune, India site will be the home of its new Drug Discovery Division....
Enzene's Pune, India site will be the home of its new Drug Discovery Division. © Enzene Bioscience

“There is a global shortage of biology services, and our clients are increasingly looking to collaborate with us much earlier in the discovery phase to expedite their progress to IND and beyond," commented Himanshu Gadgil, CEO of Enzene Biosciences. "For our big pharma partners, in addition to running the integrated programs, we provide the flexibility to easily outsource non-core activities. In particular, we have seen strong demand for high quality reagents and assay services that play a crucial role across drug discovery and development.” 

Company

Enzene Biosciences Ltd

Khalumbre, Chakan
410501 Pune
India

Company contact







Free Expert Insights

Dual‑Targeting Breakthroughs
Advancements in Bispecific Antibody Development

Dual‑Targeting Breakthroughs

Unlock the latest breakthroughs in bispecific antibody development! Download Wiley’s free Expert Insights eBook to explore cutting-edge dual-targeting strategies, advanced purification methods, and bioanalytical technologies transforming immunotherapy and cancer treatment.

Special Issue

Circular Plastics Economy
Explore the Future of Plastics

Circular Plastics Economy

This special CHEManager issue explores the industry’s pivotal shift towards a more sustainable, circular plastics value chain. Readers will find expert analysis and real-world solutions for today’s most pressing recycling and regulatory challenges.

most read